Menu

• Ask a Health Expert about BIOPSY BONE MARROW ABNORMAL
• Post Your Side Effect related to BIOPSY BONE MARROW ABNORMAL
• BIOPSY BONE MARROW ABNORMAL and FDA Warnings
• BIOPSY BONE MARROW ABNORMAL in Patients Wiki
• Report BIOPSY BONE MARROW ABNORMAL in Drug Side Effect Survey

BIOPSY BONE MARROW ABNORMAL side effect

What is BIOPSY BONE MARROW ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Isentress Side Effects Report #5623712-0
Physician from UNITED STATES reported ISENTRESS problem on Jan 24, 2008. Male patient, 50 years of age, weighting 154.0 lb, was diagnosed with hiv infection and was treated with ISENTRESS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, blood creatine increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypersensitivity, immune reconstitution syndrome, nephritis interstitial, platelet count decreased, . ISENTRESS dosage: 400MG/BID/PO. During the same period patient was treated with SUSTIVA, EPIVIR, VIDEX EC, ANDROGEL, DIFLUCAN, MEPRON, OXANDRIN, PROCRIT. Patient was hospitalized. Patient recovered.

Combivir Side Effects Report #5602541-8
COMBIVIR problem was reported by a Consumer or non-health professional from SPAIN on Jan 17, 2008. Male patient, 49 years of age, was diagnosed with hiv infection, abdominal discomfort and was treated with COMBIVIR. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, refractory anaemia with an excess of blasts, . COMBIVIR dosage: unknown. During the same period patient was treated with OMEPRAZOLE, ACYCLOVIR, METHADONE, VIREAD. Patient was hospitalized. Patient recovered.

Diovan Side Effects Report #5519198-7
Consumer or non-health professional from UNITED STATES reported DIOVAN problem on Nov 12, 2007. Male patient, 63 years of age, weighting 319.9 lb, was diagnosed with hypertension and was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, fatigue, leukaemia, white blood cell count increased, . DIOVAN dosage: unknown. During the same period patient was treated with ZESTRIL, CITALOPRAM HYDROBROMIDE, MELOXICAM. Patient recovered.

Prograf Side Effects Report #5419986-1
PROGRAF problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 41 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cerebral atrophy, encephalitis herpes, human herpesvirus 6 infection, . PROGRAF dosage: unknown. Patient recovered.


Novantrone Side Effects Report #5421458-5
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Aug 08, 2007. Female patient, 66 years of age, weighting 116.0 lb, was diagnosed with acute myeloid leukaemia and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cardiac arrest, disease progression, dyspnoea, ejection fraction decreased, electrolyte imbalance, electromechanical dissociation, febrile neutropenia, fluid overload, . NOVANTRONE dosage: unknown. During the same period patient was treated with ETOPOSIDE, ACYCLOVIR, ALLOPUINOL, CALCIUM CARBONATE, CEFEPIME, NYSTATIN, PROTONIX. Patient was hospitalized. Patient recovered.

Actos Side Effects Report #5379449-9
ACTOS problem was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 66 years of age, weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, weight decreased, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with AMARYL, ULTRACET, CYCLOBENZAPRINE. Patient died.

Actos Side Effects Report #5379449-9
Physician from UNITED STATES reported ACTOS problem on June 25, 2007. Male patient, 66 years of age, weighting 175.0 lb, was diagnosed with type 2 diabetes mellitus and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, weight decreased, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with AMARYL, ULTRACET, CYCLOBENZAPRINE. Patient died.

Rasilez Side Effects Report #5700140-0
RASILEZ problem was reported by a Physician from GERMANY on Apr 07, 2008. Male patient, 82 years of age, was treated with RASILEZ. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, prostatic operation, thrombocytopenia, . RASILEZ dosage: 150 MG/D. Patient was hospitalized. Patient recovered.

Cerezyme Side Effects Report #5712100-4
Physician from CANADA reported CEREZYME problem on Apr 03, 2008. Female patient, 19 years of age, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, bone pain, . CEREZYME dosage: unknown. Patient recovered.


Actos Side Effects Report #5378009-3
ACTOS problem was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 66 years of age, weighting 175.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with ACTOS. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, pancytopenia, weight decreased, . ACTOS dosage: 30 MG, 1 IN 1 D, PER ORAL. During the same period patient was treated with AMARYL, ULTRACET, CYCLOBENZAPRINE. Patient died.

Pamidronate Side Effects Report #5311294-2
Health Professional from UNITED STATES reported PAMIDRONATE DI problem on Apr 19, 2007. Female patient, 50 years of age, was diagnosed with hypercalcaemia of malignancy and was treated with PAMIDRONATE DI. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, blood creatinine increased, blood urea increased, glomerulonephropathy, haemoglobin decreased, nephritis interstitial, nephrosclerosis, plasma cells increased, proteinuria, . PAMIDRONATE DI dosage: 90 MG. During the same period patient was treated with INTERFERON ALFA, MELPHALAN, ZOLEDRONATE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5256261-2
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 21, 2007. Female patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: biopsy bone marrow abnormal, cardiac failure congestive, cardiogenic shock, hyperplasia, hypovolaemia, myocardial infarction, no therapeutic response, pancytopenia, pulmonary oedema, . REVLIMID dosage: 25-15 MG, QD, D 1-21, ORAL. During the same period patient was treated with DEXAMETHASONE, LASIX, LISINOPRIL, METOPROLOL TARTRATE, NOVOLIN N. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5535051-7
Consumer or non-health professional from UNITED STATES reported NATALIZUMAB problem on Nov 20, 2007. Female patient, 62 years of age, weighting 170.4 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, biopsy bone marrow abnormal, blepharitis, blood albumin decreased, cardiac aneurysm, cognitive disorder, condition aggravated, conjunctival hyperaemia, culture urine positive, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with NEUTONTIN, DETROL, MIRAPEX, VYTORIN, SYNTHROID, HYDROCHLOROTHIAZIDE, FOSAMAX, DARVOCET. Patient was hospitalized. Patient recovered.

Imatinib Side Effects Report #5549550-5
IMATINIB problem was reported by a Health Professional from ITALY on Dec 03, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB dosage: 600 MG/D. Patient recovered.


Cipro Side Effects Report #5575055-1
Health Professional from UNITED STATES reported CIPRO problem on Dec 21, 2007. Female patient, 50 years of age, weighting 186.4 lb, was diagnosed with peritonitis bacterial, prophylaxis and was treated with CIPRO. After drug was administered, patient experienced the following problems/side effects: abdominal distension, biopsy bone marrow abnormal, confusional state, dyspnoea, hypersplenism, neutropenia, white blood cell count decreased, . CIPRO dosage: unknown. Patient recovered.

Zometa Side Effects Report #5483295-5
ZOMETA problem was reported by a Physician from JAPAN on Oct 04, 2007. Male patient, 80 years of age, was diagnosed with bone lesion, multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, bone debridement, bone disorder, cataract operation, diarrhoea, facial palsy, loose tooth, multiple myeloma, . ZOMETA dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with ALKERAN, PREDONINE, FAMOTIDINE, LOXONIN, SELBEX, TERNELIN, VITAMEDIN CAPSULE, FOLIAMIN. Patient was hospitalized. Patient recovered.

Neulasta Side Effects Report #5447414-9
Consumer or non-health professional from UNITED KINGDOM reported NEULASTA problem on Aug 30, 2007. Female patient, 68 years of age, was diagnosed with anaemia of malignant disease and was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, biopsy bone marrow abnormal, fatigue, feeling cold, incorrect dose administered, influenza like illness, loss of consciousness, malaise, megakaryocytes increased, . NEULASTA dosage: unknown. During the same period patient was treated with ARANESP, NEUPOGEN, CYCLOPHOSPHAMIDE, FOLIC ACID, FERROUS SULPHATE, RITUXIMAB. Patient was hospitalized. Patient recovered.

Zometa Side Effects Report #5449596-1
ZOMETA problem was reported by a Physician from JAPAN on Sept 04, 2007. Male patient, 80 years of age, was diagnosed with bone lesion, multiple myeloma and was treated with ZOMETA. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, bone debridement, bone disorder, cataract operation, diarrhoea, facial palsy, loose tooth, multiple myeloma, . ZOMETA dosage: 4 MG EVERY 4 WEEKS. During the same period patient was treated with ALKERAN, PREDONINE, FAMOTIDINE, LOXONIN, SELBEX, TERNELIN, VITAMEDIN CAPSULE, FOLIAMIN. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5469455-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 25, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, cholelithiasis, colitis, diarrhoea, haematochezia, malnutrition, nausea, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN. Patient recovered.


Revlimid Side Effects Report #5423015-3
REVLIMID problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: asthenia, biopsy bone marrow abnormal, disease progression, epistaxis, fatigue, hypercalcaemia, hyponatraemia, malaise, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 15-10MG, DAILY, ORAL; 5 MG, 1 IN 1 D, ORAL. Patient died on 06/17/2007.

Voltaren Side Effects Report #5424648-0
Consumer or non-health professional from AUSTRIA reported VOLTAREN problem on Aug 17, 2007. Male patient was diagnosed with sciatica and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, prostatic specific antigen increased, . VOLTAREN dosage: 50 MG, UNK. Patient was hospitalized. Patient recovered.

Clarithromicina Side Effects Report #5430911-X
CLARITHROMICINA RANBAXY problem was reported by a Health Professional from TURKEY on Aug 13, 2007. Female patient, 65 years of age, was treated with CLARITHROMICINA RANBAXY. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, biopsy bone marrow abnormal, cardio-respiratory arrest, pancytopenia, toxic epidermal necrolysis, . CLARITHROMICINA RANBAXY dosage: unknown. During the same period patient was treated with CEFTAZIDIME PENTAHYDRATE, METHYLPREDNISOLONE, IMIPENEM, AMIKACIN SULPHATE. Patient was hospitalized. Patient died.

Cytarabine Side Effects Report #5378382-6
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.

Imatinib Side Effects Report #5394985-7
IMATINIB MESYLATE problem was reported by a Health Professional from ITALY on July 12, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB MESYLATE dosage: 600 MG/D. Patient recovered.

Thalidomide Side Effects Report #5397244-1
Physician from UNITED KINGDOM reported THALIDOMIDE problem on July 12, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, biopsy bone marrow abnormal, blood immunoglobulin a increased, blood lactate dehydrogenase increased, blood viscosity increased, cardiomegaly, chest discomfort, chest x-ray abnormal, condition aggravated, . THALIDOMIDE dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, ADRIAMYCIN PFS, PLAVIX, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 06/14/2007.

Cytarabine Side Effects Report #5378382-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Female patient, weighting 130.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, biopsy bone marrow abnormal, blast cells present, cholelithiasis, colitis, febrile neutropenia, malnutrition, oral intake reduced, . CYTARABINE dosage: 1162 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.

Imatinib Side Effects Report #5394985-7
Health Professional from ITALY reported IMATINIB MESYLATE problem on July 12, 2007. Male patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: aplasia, biopsy bone marrow abnormal, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, bone marrow necrosis, erythroblast count increased, hyperpyrexia, pain in extremity, . IMATINIB MESYLATE dosage: 600 MG/D. Patient recovered.

Thalidomide Side Effects Report #5397244-1
THALIDOMIDE problem was reported by a Physician from UNITED KINGDOM on July 12, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: angiocentric lymphoma, biopsy bone marrow abnormal, blood immunoglobulin a increased, blood lactate dehydrogenase increased, blood viscosity increased, cardiomegaly, chest discomfort, chest x-ray abnormal, condition aggravated, . THALIDOMIDE dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, ADRIAMYCIN PFS, PLAVIX, METOPROLOL SUCCINATE. Patient was hospitalized. Patient died on 06/14/2007.

Tegretol Side Effects Report #5738125-0
Health Professional from UNITED STATES reported TEGRETOL problem on Oct 02, 2007. Male patient, 68 years of age, weighting 218.0 lb, was diagnosed with convulsion, gliomatosis cerebri and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: aplastic anaemia, biopsy bone marrow abnormal, haematocrit decreased, hemiparesis, leukopenia, lymphocyte count increased, neutropenia, neutrophil count decreased, paraesthesia, . TEGRETOL dosage: 400 MG, QD, ORAL. During the same period patient was treated with TEMODAR. Patient was hospitalized. Patient recovered.

Procrit Side Effects Report #5691594-7
PROCRIT problem was reported by a Physician from UNITED STATES on Mar 25, 2008. Female patient, weighting 90.17 lb, was diagnosed with renal failure chronic and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, hyperparathyroidism, pneumonia, . PROCRIT dosage: unknown. During the same period patient was treated with COREG, PHENYTOIN. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5370755-0
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Oct 16, 2006. Male patient was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, blood product transfusion dependent, hypochromasia, platelet count decreased, . GLEEVEC dosage: unknown. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5323453-3
GLEEVEC problem was reported by a Physician from AUSTRALIA on May 04, 2007. Female patient, 69 years of age, was diagnosed with metastases to liver and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: anaemia, biopsy bone marrow abnormal, blood immunoglobulin m increased, diarrhoea, protein total increased, reflux oesophagitis, rouleaux formation, tumour necrosis, waldenstrom's macroglobulinaemia, . GLEEVEC dosage: 400 MG, QD. During the same period patient was treated with VITAMINS. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5315595-3
Physician from UNITED STATES reported NATALIZUMAB problem on Apr 17, 2007. Male patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, biopsy bone marrow abnormal, blood glucose increased, cushingoid, epistaxis, feeling cold, hypoaesthesia, idiopathic thrombocytopenic purpura, immune system disorder, . NATALIZUMAB dosage: unknown. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5565338-3
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 28, 2007. Female patient, 62 years of age, weighting 170.4 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, aneurysm, biopsy bone marrow abnormal, blepharitis, cognitive disorder, disorientation, dizziness, dysphagia, hepatitis, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with NEURONTIN, DETROL, MIRAPEX, VYTORIN, SYNTHROID, HYDROCHLOROTHIAZIDE, FOSAMAX, DARVOCET. Patient was hospitalized. Patient recovered.

Clomiphene Side Effects Report #5420156-1
Consumer or non-health professional from JAPAN reported CLOMIPHENE CITRATE problem on Aug 02, 2007. Female patient, 31 years of age, weighting 98.99 lb, was treated with CLOMIPHENE CITRATE. After drug was administered, patient experienced the following problems/side effects: aplasia pure red cell, ascites, biopsy bone marrow abnormal, bone marrow failure, haemoconcentration, hyponatraemia, ovarian hyperstimulation syndrome, pregnancy, . CLOMIPHENE CITRATE dosage: unknown. During the same period patient was treated with MENOTROPINS, CHORIONIC GONADTROPIN. Patient was hospitalized. Patient recovered.

Depakote Side Effects Report #5771727-4
DEPAKOTE ER problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2008. Female patient, weighting 166.1 lb, was diagnosed with depression, bipolar disorder, back pain, migraine and was treated with DEPAKOTE ER. After drug was administered, patient experienced the following problems/side effects: alopecia, anaemia, biopsy bone marrow abnormal, contusion, fall, head injury, walking aid user, weight decreased, . DEPAKOTE ER dosage: unknown. During the same period patient was treated with DEPAKOTE ER, OXYCODONE HYDROCHLORIDE, FIORCET, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5775499-9
Physician from CANADA reported GLEEVEC problem on May 23, 2008. Male patient, weighting 183.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abscess drainage, abscess intestinal, biopsy bone marrow abnormal, biopsy liver abnormal, cachexia, catheter related complication, chloroma, cholangitis sclerosing, chronic myeloid leukaemia, . GLEEVEC dosage: 800 MG, QD. During the same period patient was treated with HYDREA, ATENOLOL, ALBUMIN, ANAGRELIDE, INNOHEP, ASPIRIN, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Lantus Side Effects Report #5746629-X
LANTUS problem was reported by a Physician from GERMANY on May 19, 2008. Male patient, 82 years of age, weighting 191.8 lb, was diagnosed with hypertension and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biopsy bone marrow abnormal, haematocrit decreased, haemoglobin decreased, monocytosis, pancytopenia, prostatic operation, red blood cell count decreased, . LANTUS dosage: 4 MG, QD. During the same period patient was treated with AMLODIPINE, ASPIRIN, ISOSORBIDE DINITRATE, RASILEZ. Patient was hospitalized. Patient recovered.

Vitamins Side Effects Report #5275374-2
Physician from GERMANY reported VITAMINS NOS problem on Mar 14, 2007. Female patient, 48 years of age, weighting 92.59 lb, was diagnosed with breast cancer female and was treated with VITAMINS NOS. After drug was administered, patient experienced the following problems/side effects: anaemia, apathy, biopsy bone marrow abnormal, bone marrow failure, depression, erythropoiesis abnormal, fatigue, haematocrit decreased, haemoglobin abnormal, . VITAMINS NOS dosage: unknown. During the same period patient was treated with FEMARA. Patient recovered.